Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
PACIRA
(NQ:
PCRX
)
74.43
USD
-2.02 (-2.64%)
Official Closing Price
/ Updated:
8:10 PM EST, Mar 7, 2014
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
460,365
Open
77.06
Bid (Size)
74.39 (600)
Ask (Size)
74.44 (5900)
Prev. Close
76.45
Today's Range
73.24 - 79.01
52wk Range
24.70 - 83.41
Shares Outstanding
33,714,015
Dividend Yield
N/A
Performance
YTD
+31.69%
+31.69%
1 Month
+16.48%
+16.48%
3 Month
+43.49%
+43.49%
6 Month
+103.08%
+103.08%
1 Year
+185.17%
+185.17%
Top News
More News
Stock Price Movements, Official Platinum Sponsor Status, Conference Schedules, Appointments and Clinical Trial Results - Analyst Notes on Intuitive, Agilent, Teleflex, WuXi PharmaTech, and Pacira
March 05, 2014
from
PR Newswire
Pacira Pharmaceuticals Inc. Appoints Industry Expert Yvonne Greenstreet to its Board of Directors
March 06, 2014
from
Business Wire News Releases
More News
Read More
Pacira Pharmaceuticals, Inc. Webcast Replay of 2013 Financial Results Conference Call
February 25, 2014
from
GlobeNewswire News Releases
Pacira Pharmaceuticals Announces EXPAREL® Data Presentations at 2014 Annual Meeting of the American Academy of Orthopedic Surgeons
March 05, 2014
from
Business Wire News Releases
Pacira Pharmaceuticals, Inc. Announces EXPAREL Phase 3 Clinical Trial in Femoral Nerve Block Meets Primary Efficacy Endpoint
February 27, 2014
from
Business Wire News Releases
Pacira Pharmaceuticals, Inc. to Present at the Barclays Global Healthcare Conference
February 26, 2014
from
Business Wire News Releases
Pacira Pharmaceuticals, Inc. Reports 2013 Financial Results: Fourth Quarter EXPAREL Revenues Increase 53 Percent Over Third Quarter
February 25, 2014
from
Business Wire News Releases
Pacira Pharmaceuticals, Inc. Announces Timing for 2013 Financial Results Webcast and Conference Call
February 11, 2014
from
Business Wire News Releases
Data Update Supports Infiltration with EXPAREL® into the Transversus Abdominis Plane for Postsurgical Pain Management
January 29, 2014
from
Business Wire News Releases
Pacira Pharma (PCRX) to Present EXPAREL Data at AAOS
March 05, 2014
from
StreetInsider.com News Articles
Pacira pain drug succeeds in late-stage trial
February 27, 2014
category
companyNews
from
Reuters: Company News
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here